GH

Guardant Health
NASDAQ

Real-time Quotes | Nasdaq Last Sale

71.37
+1.27
+1.81%
After Hours: 71.37 0 0.00% 16:58 01/24 EST
OPEN
68.94
PREV CLOSE
70.10
HIGH
71.86
LOW
65.21
VOLUME
1.71M
TURNOVER
--
52 WEEK HIGH
181.07
52 WEEK LOW
65.21
MARKET CAP
7.26B
P/E (TTM)
-17.6309
1D
5D
1M
3M
1Y
5Y
After Plunging 27.6% in 4 Weeks, Here's Why the Trend Might Reverse for Guardant Health (GH)
Guardant Health (GH) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential tr...
Zacks · 4d ago
Guardant Health to Present Data Highlighting the Clinical Utility of Its Liquid Biopsy Tests in Gastrointestinal Cancers at ASCO GI Cancers Symposium
REDWOOD CITY, Calif., January 19, 2022--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will present data highlighting the clinical utility of its liquid biopsy tests in the treatment and management of early- to...
Business Wire · 5d ago
Guardant Health Enrolls First Patient In SHIELD LUNG Study To Evaluate Accuracy Of Its Blood Test To Detect Lung Cancer In High-Risk Adults
Guardant Health, Inc. (NASDAQ:GH), a leading precision oncology company, announced today the enrollment of the first patient in the SHIELD (Screening for HIgh-frEquency maLignant Disease) LUNG study, a nearly
Benzinga · 6d ago
Here’s Why You Must Consider Investing in Guardant Health (GH)
ClearBridge Investments, an investment management firm, published its “Multi-Cap Growth Strategy” third quarter 2021 investor letter – a copy of which can be downloaded here. The ClearBridge Multi Cap Growth Strategy underperformed its Russell 3000 Growth ...
Insider Monkey · 01/10 14:08
Vigilare Wealth Management Buys BTC iShares MSCI USA Min Vol Factor ETF, Coca-Cola Co, Guardant ...
Investment company Vigilare Wealth Management (Current Portfolio) buys BTC iShares MSCI USA Min Vol Factor ETF, Coca-Cola Co, Guardant Health Inc, Linde PLC, Pfizer Inc, sells iShares Russell 2000 ETF, Verizon Communications Inc, First Trust NASDAQ Clean E...
GuruFocus.com · 01/07 22:38
BRIEF-Guardant Health And Foundation Medicine Reach Settlement In Digital Sequencing Technology Litigation
reuters.com · 01/07 22:34
Guardant Health to settle digital sequencing patent litigation with Foundation Medicine
Guardant Health (NASDAQ:GH) reaches an agreement to settle all pending litigation concerning its digital sequencing technology patents with Foundation Medicine. Foundation Medicine will pay GH $25M as well as future
Seekingalpha · 01/07 22:26
Guardant Health and Foundation Medicine Reach Settlement in Digital Sequencing Technology Litigation
REDWOOD CITY, Calif., January 07, 2022--Guardant Health, Inc. (Nasdaq: GH) today announced that it has reached an agreement to settle all pending litigation concerning the company’s digital sequencing technology patents with Foundation Medicine, Inc. Pursu...
Business Wire · 01/07 22:15
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of GH. Analyze the recent business situations of Guardant Health through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 15 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

46.67%Strong Buy
46.67%Buy
6.67%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average GH stock price target is 166.75 with a high estimate of 185.00 and a low estimate of 150.00.
High185.00
Average166.75
Low150.00
Current 71.37
EPS
Actual
Estimate
-0.92-0.69-0.46-0.23
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Institutional Holdings
Institutions: 492
Institutional Holdings: 99.45M
% Owned: 97.83%
Shares Outstanding: 101.66M
TypeInstitutionsShares
Increased
131
10.74M
New
33
1.07M
Decreased
120
3.55M
Sold Out
70
3.17M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+1.12%
Pharmaceuticals & Medical Research
-0.55%
Key Executives
Chairman/Co-Chief Executive Officer/Director
Helmy Eltoukhy
President/Co-Chief Executive Officer/Director
Amirali Talasaz
Chief Financial Officer
Michael Bell
Senior Vice President/General Counsel/Secretary
John Saia
Other
Craig Eagle
Other
Michael Wiley
Lead Director/Independent Director
Ian Clark
Director
Myrtle Potter
Independent Director
Vijaya Gadde
Independent Director
Bahija Jallal
Independent Director
Meghan Joyce
Independent Director
Samir Kaul
Independent Director
Stanley Meresman
No Data
About GH
Guardant Health, Inc. is a precision oncology company. The Company is focused on helping conquer cancer through use of its blood-based tests, data sets and advanced analytics. It has developed its Guardant360, Guardant360 CDx and GuardantOMNI liquid biopsy-based tests for advanced stage cancer. It also developed its Guardant Reveal liquid biopsy-based test for residual and recurring cancer to address the need in Stage II-III colorectal cancer. Its Guardant360 test is a molecular diagnostic test measuring 74 cancer-related genes. Its Guardant360 CDx test is a liquid biopsy test measuring 55 cancer related genes. Its GuardantOMNI test has a broader 500-gene panel, all of which analyze circulating tumor Deoxyribonucleic Acid (DNA) in blood. The Company's tests are used by biopharmaceutical companies for a range of applications, including identifying target patient populations to accelerate translational science research and clinical trial enrollment, and companion diagnostic development.

Webull offers kinds of Guardant Health Inc stock information, including NASDAQ:GH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GH stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading GH stock methods without spending real money on the virtual paper trading platform.